Biopharma Trends and Outlook Posts
Creating Effective Leachables and Extractables Testing: Whose Responsibility Is It?
Published: 2015-04-20
Published: 2015-04-20
The problem of leachables and extractables (L&E) in single-use devices continues to hound both suppliers and end-users, and remains one of the more challenging issues inhibiting regulatory acceptance of single-use devices.
Wit...
Single-use, disposable bioprocessing reached the Billion-Dollar club this year, and judging by suppliers’ sales growth, it continues to gain broad industry acceptance. The many advantages offered to CMOs and biotherapeutic developers...
Biopharmaceutical companies that get stuck with legacy technologies, including older stainless steel equipment, and older processes, end up watching as competitors transition to more efficient, cost-effective platforms. But this isn’...
Participate in this year’s 9th Annual Report! Be part of the bio-industry’s most authoritative, comprehensive analysis! Participants contribute to industry benchmarking, are first to receive a summary,...
BioPlan Associates’ 8th Annual Report and Survey of Biopharmaceutical Manufacturing, 2011, identifies the growing need for standards to support rapidly emerging and evolving single use, disposable technologies.&nb...
CMOs are providing more advanced outsourcing services to remain competitive, as economic pressures drive demands for greater productivity. In our current study, the 8th Annual Report and Survey of Biopharmaceutical Manufacturing...
Single use technologies are strong change agents in biopharma manufacturing. Disposable devices emerge once ag...
Budgets for the biomanufacturing sector of biotech show a significant upswing from recent years’ freezes and cuts. In fact, respondents to BioPlan’s 8th Annual Report and Survey of Biopharmaceutical Manufacturing...
